Bioavailability, Drug Delivery Systems, Gene Therapy and Marketing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bioavailability

Drug Delivery Systems

Gene Therapy

Marketing

Biopharmaceutical Excipient Manufacturing – Current Scenario and Future Trends

Roots Analysis

MARCH 13, 2022

In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines and gene therapies), by the US FDA, have steadily risen. Future Evolution of Biopharmaceutical Excipient Manufacturing Market. Our Social Media Platform. Web: [link]. LinkedIn: [link].

Manufacturing

Manufacturing Drug Delivery Marketing Drug Delivery Systems

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

XTalks

AUGUST 30, 2022

CNS drugs take more than a year longer to develop and are less than half as likely to receive marketing approval compared to other drugs, according to a 2014 study by the Tufts Center for the Study of Drug Development. Next Steps for Targeted CNS Delivery. Why is it Difficult to Develop CNS Therapeutics?

Trials

Trials Drug Delivery Drugs Gene

Clinical Research Informer

Biopharmaceutical Excipient Manufacturing – Current Scenario and Future Trends

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

Stay Connected